EUVIMEDEUVIMED entdecken
Multizentrische Studie

Efficacy of Platinum-based Chemotherapy for Platinum-sensitive Recurrent Ovarian Cancer During PARP Inhibitor Treatment: A Multicenter Retrospective Study

Eriko Takatori, Tadahiro Shoji, Ami Jo, Miku Musashi, Shunsuke Tatsuki, Nanako Jonai, Yohei Chiba, Sho Sato, Yoshitaka Kaido, Takayuki Nagasawa, Masahiro Kagabu, Fumiaki Takahashi und 2 weitere

Anticancer Research · 2025-12 · 45 (12) · 5773-5783

DOI: 10.21873/anticanres.17910 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Anticancer Research, online erschienen am 29.11.2025. Verfasst von Eriko Takatori und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Yahaba, Japan. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Poly(ADP-ribose) Polymerase Inhibitors, Antineoplastic Combined Chemotherapy Protocols, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsPoly(ADP-ribose) Polymerase InhibitorsAntineoplastic Combined Chemotherapy ProtocolsNeoplasm Recurrence, LocalHumansFemaleMiddle AgedRetrospective StudiesAgedCarboplatinAdultCisplatinPaclitaxelTreatment OutcomeOrganoplatinum CompoundsDoxorubicinPlatinum

Stichwörter der Autor:innen

Ovarian cancerPARP inhibitorsplatinum-based chemotherapyplatinum-sensitive recurrence

Substanzen

Poly(ADP-ribose) Polymerase InhibitorsCarboplatinCisplatinPaclitaxelnedaplatinOrganoplatinum CompoundsDoxorubicinPlatinum

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Yahaba, Japan.
  • Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Yahaba, Japan; tshoji@iwate-med.ac.jp.
  • Department of Information Science, Iwate Medical University, Yahaba, Japan.
  • Department of Obstetrics and Gynecology, Hachinohe Red Cross Hospital, Hachinohe, Japan.

Zitieren

APA

Takatori, E., Shoji, T., Jo, A., Musashi, M., Tatsuki, S., Jonai, N., Chiba, Y., Sato, S., Kaido, Y., Nagasawa, T., Kagabu, M., Takahashi, F., Aida, T., & Baba, T. (2025). Efficacy of Platinum-based Chemotherapy for Platinum-sensitive Recurrent Ovarian Cancer During PARP Inhibitor Treatment: A Multicenter Retrospective Study. Anticancer Research, 45(12), 5773-5783. https://doi.org/10.21873/anticanres.17910

Vancouver

Takatori E, Shoji T, Jo A, Musashi M, Tatsuki S, Jonai N, et al. Efficacy of Platinum-based Chemotherapy for Platinum-sensitive Recurrent Ovarian Cancer During PARP Inhibitor Treatment: A Multicenter Retrospective Study. Anticancer Research. 2025;45(12):5773-5783. doi:10.21873/anticanres.17910

BibTeX
@article{Takatori2025,
  author = {Takatori, Eriko and Shoji, Tadahiro and Jo, Ami and Musashi, Miku and Tatsuki, Shunsuke and Jonai, Nanako and Chiba, Yohei and Sato, Sho and Kaido, Yoshitaka and Nagasawa, Takayuki and Kagabu, Masahiro and Takahashi, Fumiaki and Aida, Takeshi and Baba, Tsukasa},
  title = {Efficacy of Platinum-based Chemotherapy for Platinum-sensitive Recurrent Ovarian Cancer During PARP Inhibitor Treatment: A Multicenter Retrospective Study},
  journal = {Anticancer Research},
  year = {2025},
  volume = {45},
  number = {12},
  pages = {5773--5783},
  doi = {10.21873/anticanres.17910}
}
Kostenlos starten →